Diamedica
DMAC
Diamedica (DMAC) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $12.00 | Aug 11, 2026 |
| Cantor Fitzgerald | Initiated Coverage | Overweight | $25.00 | Nov 14, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 | Aug 15, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 from $10.00 | Jul 18, 2025 |
| Craig-Hallum | Maintained | Buy | $11.00 from $8.00 | Jul 18, 2025 |
| Lake Street | Maintained | Buy | $14.00 from $11.00 | Jul 18, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 | May 29, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 from $7.00 | Mar 19, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Nov 15, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Oct 10, 2024 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $7.00 | Oct 7, 2024 |
| Oppenheimer | Maintained | Outperform | $6.00 | Aug 16, 2024 |
| Craig-Hallum | Initiated Coverage | Buy | $8.00 | Apr 24, 2024 |
| Oppenheimer | Maintained | Outperform | $6.00 from $7.00 | Mar 21, 2024 |
| Craig-Hallum | Maintained | Buy | $8.00 from $11.00 | Mar 21, 2024 |
| Oppenheimer | Upgraded | Perform → Outperform | $7.00 | Jun 22, 2023 |
Frequently asked questions
What is the latest analyst rating on DMAC?
On Aug 11, 2026, HC Wainwright & Co. maintained Diamedica at Buy with a price target of $12.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.